GAIN THERAPEUTICS, INC Taxes Payable, Current
GAIN THERAPEUTICS, INC (GANX) had Taxes Payable, Current of $74.68 thousand as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:TaxesPayableCurrent · last filed 2024-05-14
- 2024-03-31: Taxes Payable, Current $74.68K.
- 2023-12-31: Taxes Payable, Current $48.97K.
- 2023-09-30: Taxes Payable, Current $69.26K.
- 2023-06-30: Taxes Payable, Current $184.69K.
| Period end | Taxes Payable, Current |
|---|---|
| 2024-03-31 | $74.68K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $48.97K 10-Q · filed 2024-05-14 |
| 2023-09-30 | $69.26K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $184.69K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $120.78K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $107.31K 10-K · filed 2024-03-26 |
| 2022-09-30 | $12.85K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $10.06K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.04K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $380.00 10-K · filed 2023-03-23 |
| 2021-09-30 | $10.48K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $6.84K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.53K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.07K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |